Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
Basith, S., Manavalan, B., Hwan Shin, T
Some users describe flavors becoming stronger or unpleasant while on the medications, though individual experiences seem to vary: Siobhan, a Los Angelesbased writer, who has been taking Wegovy since 2021 and withheld her last name for privacy, says she still finds fatty foods such as French fries appealingbut her favorite food, panang curry, has become too bitter
2- acute and chronic treatment of patients with an inborn error of metabolism , haemodialysis that results in secondary carnitine deficiency characterised by severe muscle cramps and weakness .lack of energy and anaemia